ZRANB3 and neoplasm: Moreover, the opposite outcomes observed in different kidney cancer subtypes, which differ for their immune-infiltrative traits and specific biomarkers expression, suggest a tissue-specific tumour regulatory function for ZRANB3 [102,103].